S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
NASDAQ:MLEC

Moolec Science (MLEC) Stock Price, News & Analysis

$1.40
+0.02 (+1.45%)
(As of 04/19/2024 08:51 PM ET)
Today's Range
$1.16
$1.40
50-Day Range
$1.19
$1.93
52-Week Range
$1.15
$4.40
Volume
217,700 shs
Average Volume
321,804 shs
Market Capitalization
$52.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Moolec Science MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
292.9% Upside
$5.50 Price Target
Short Interest
Healthy
0.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.06 out of 5 stars

Consumer Staples Sector

102nd out of 134 stocks

Holding & Other Investment Offices Industry

4th out of 9 stocks

MLEC stock logo

About Moolec Science Stock (NASDAQ:MLEC)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

MLEC Stock Price History

MLEC Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Moolec Science S.A.
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Moolec Science announces capital raise
Moolec Science SA (MLEC)
See More Headlines
Receive MLEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2024
Today
4/22/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:MLEC
Fax
N/A
Employees
45
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.50
High Stock Price Target
$6.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+292.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$900,000.00
Book Value
$0.27 per share

Miscellaneous

Free Float
30,089,000
Market Cap
$52.58 million
Optionable
Not Optionable
Beta
-0.46
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Gaston Paladini M.B.A. (Age 43)
    Co-Founder, CEO & Director
  • Mr. Henk Hoogenkamp Ph.D. (Age 37)
    Co-Founder & Chief Product Officer
  • Mr. Martin Salinas Ph.D. (Age 42)
    Chief of Technology & Co-Founder
  • Mr. Jose Lopez Lecube M.B.A. (Age 41)
    CFO & Director
  • Mr. Amit Dhingra Ph.D. (Age 54)
    Chief Science Officer
  • Ms. Catalina Jones B.A. (Age 38)
    Chief of Staff & Sustainability

MLEC Stock Analysis - Frequently Asked Questions

Should I buy or sell Moolec Science stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Moolec Science in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MLEC shares.
View MLEC analyst ratings
or view top-rated stocks.

What is Moolec Science's stock price target for 2024?

3 equities research analysts have issued 12 month price targets for Moolec Science's stock. Their MLEC share price targets range from $5.00 to $6.00. On average, they predict the company's share price to reach $5.50 in the next twelve months. This suggests a possible upside of 292.9% from the stock's current price.
View analysts price targets for MLEC
or view top-rated stocks among Wall Street analysts.

How have MLEC shares performed in 2024?

Moolec Science's stock was trading at $2.46 on January 1st, 2024. Since then, MLEC shares have decreased by 43.1% and is now trading at $1.40.
View the best growth stocks for 2024 here
.

Are investors shorting Moolec Science?

Moolec Science saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 5,100 shares, a drop of 64.1% from the March 15th total of 14,200 shares. Based on an average daily volume of 318,900 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.1% of the company's shares are sold short.
View Moolec Science's Short Interest
.

When is Moolec Science's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our MLEC earnings forecast
.

How were Moolec Science's earnings last quarter?

Moolec Science SA (NASDAQ:MLEC) issued its earnings results on Wednesday, March, 13th. The company reported ($0.05) EPS for the quarter, meeting analysts' consensus estimates of ($0.05). The business had revenue of $0.25 million for the quarter, compared to the consensus estimate of $0.63 million.

How do I buy shares of Moolec Science?

Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MLEC) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners